Bellevue Group’s Eupraxia Pharmaceuticals EPRX Stock Holding History
Bought
Maintained
Sold
Other funds holding EPRX
Bellevue Group's EPRX Position: Q3 2026 in Review
Bellevue Group opened a new position in Eupraxia Pharmaceuticals (EPRX) in Q3 2026: 2,595,139 shares worth $23.6M. The stake represents 0.49% of the portfolio and ranks #46 among its holdings.
70 funds tracked by Wall St. Rank hold EPRX as of Q3 2026.
- Bellevue Group held 2,595,139 shares of Eupraxia Pharmaceuticals worth $23.6M as of Q3 2026.
- Eupraxia Pharmaceuticals was a new Bellevue Group position in Q3 2026.
- Eupraxia Pharmaceuticals made up 0.49% of Bellevue Group's portfolio in Q3 2026, its #46 holding.
- 70 funds tracked by Wall St. Rank held Eupraxia Pharmaceuticals as of Q3 2026.
Based on Bellevue Group's 13F filing for Q3 2026, filed 16 Nov 2026.